Existing investor Samsung Next returned for a $60m series C round as Healthy.io secured regulatory clearance for its app-based kidney disease test.

Israel-based medical device manufacturer Healthy.io completed a $60m series C round today backed by Samsung Next, an early-stage technology investment fund owned by electronics producer Samsung. Venture capital firm Corner Ventures led the round while investment holding company Ansonia Holdings and VC firms Joy Capital and Aleph also took part. Healthy.io has created an app-based…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.